Dobutamine: Clinical Trials

14 trials of Dobutamine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 4 unknown, 1 recruiting, 1 suspended. 14 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 414Completed 7, Unknown 4, Recruiting 1, Suspended 1, Withdrawn 1

Follow Dobutamine: new trials by email Literature Review of Dobutamine trials Research Report on Dobutamine

Trials (filtered) newest first · largest first

All 14 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Outcomes of Levosimendan Versus Dobutamine Versus Milrinone in Cases With Acute Decompensated Heart Failure With Impaired Renal Function
Levosimendan, Dobutamine, Milrinone - Acute Decompensated Heart Failure (ADHF), Cardiorenal Syndrome (CRS)
Phase 4CompletedAin Shams University602022-06-012026-09-21
CAPITAL DOREMI 2: Inotrope Versus Placebo Therapy for Cardiogenic Shock
Dobutamine, Milrinone, Normal Saline - Shock, Cardiogenic
Phase 4RecruitingOttawa Heart Institute Research Corporation3462022-03-052026-05-01
Effect of Dobutamine on Hepatic Blood Flow During Goal-directed Hemodynamic Therapy
Dobutamine Hydrochloride - General Anesthesia
Phase 4CompletedUniversity Hospital, Ghent582021-09-142023-08-01
Influence of Continuous Administration of Phenylephrine Versus Dobutamine on Spinal Oxygen Saturation, Measured With Near-infrared Spectroscopy (NIRS).
Phenylephrine, Dobutamine - Nfuence of Vasoactive Medication on Spinal Oxygenation
Phase 4CompletedUniversity Hospital, Ghent362019-07-042022-12-12
Intravenous Vasodilator vs. Inotropic Therapy in Patients With Heart Failure
Sodium nitroprusside, Dobutamine, Furosemide - Acute Heart Failure
Phase 4WithdrawnMontefiore Medical Center2018-05-012018-10-31
Milrinone Versus Dobutamine in Critically Ill Patients
Milrinone, Dobutamine - Low Cardiac Output Syndrome, Cardiogenic Shock
Phase 4CompletedOttawa Heart Institute Research Corporation1922017-08-302020-06-30
Levosimendan Versus Dobutamine in Cardiopatic Patients Undergoing Major Non Cardiac Surgery
Levosimendan, Dobutamine - Cardiovascular Diseases
Phase 4UnknownAzienda Policlinico Umberto I402013-12-012013-12-17
Outcome and Safety of Intermittent Dobutamine Infusion at a Day-Care Center in Advanced Heart Failure Patients
Dobutamine, Normal Saline - Heart Failure
Phase 4UnknownSheba Medical Center602013-10-012013-08-30
The Effects of Dobutamine on Postoperative Cardiac Function in Aortic Valve Replacement
Dobutamine - Heart Failure
Phase 4SuspendedUniversity of Aarhus102011-06-012013-08-07
Dopamine Versus Dobutamine for Treatment of Arterial Hypotension in Term and Preterm Neonates
Dobutamine, Dopamine - Arterial Hypotension
Phase 4UnknownUniversity of Ulm202011-06-012016-04-06
The Effects of Levosimendan During Mitral Valve Surgery
Levosimendan, Dobutamine - Mitral Valve Stenosis With Incompetence or Regurgitation
Phase 4CompletedKartal Kosuyolu Yuksek Ihtisas Education and Research Hospital1402009-07-012013-10-25
Assessment of the Effects of Pressors on Graft Blood Flow After Free Tissue Transfer Surgery
Epinephrine, Norepinephrine, Dobutamine - Oral Cancer, Head and Neck Cancer
Phase 4CompletedOxford University Hospitals NHS Trust252008-10-012011-08-16
Arterial Pressure Based Cardiac Output for Goal-Directed Therapy in Abdominal Surgery
Ringers lactate, hydroxyethyl starch; norepinephrine, dobutamine, Goal-directed hemodynamic therapy, Standard of care - Major Abdominal Surgery
Phase 4CompletedKlinikum Ludwigshafen602007-10-012009-12-23
Microcirculation Guided Therapy Versus "Standard Treatment" of Severe Sepsis
Dopamine, dobutamine, enoximone - Severe Sepsis, Microcirculation
Phase 4UnknownOnze Lieve Vrouwe Gasthuis802007-06-012008-01-22

Conditions studied

Heart Failure (2)  ·  Hypotension (2)  ·  Shock, Cardiogenic (2)  ·  Acute Coronary Syndrome (1)  ·  Cardiac Output, Low (1)  ·  Cardio-Renal Syndrome (1)  ·  Cardiovascular Diseases (1)  ·  Gastroesophageal Reflux (1)  ·  Head and Neck Neoplasms (1)  ·  Mouth Neoplasms (1)  ·  Pulmonary Edema (1)  ·  Sepsis (1)  ·  Shock (1)

Sponsors

Ottawa Heart Institute Research Corporation (2)  ·  University Hospital, Ghent (2)  ·  Ain Shams University (1)  ·  Azienda Policlinico Umberto I (1)  ·  Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital (1)  ·  Klinikum Ludwigshafen (1)  ·  Montefiore Medical Center (1)  ·  Onze Lieve Vrouwe Gasthuis (1)  ·  Oxford University Hospitals NHS Trust (1)  ·  Sheba Medical Center (1)  ·  University of Aarhus (1)  ·  University of Ulm (1)

Countries

Belgium (2)  ·  Canada (2)  ·  Germany (2)  ·  United States (2)  ·  Denmark (1)  ·  Egypt (1)  ·  Israel (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Turkey (Türkiye) (1)  ·  United Kingdom (1)

Top investigators

Ayse Baysal, MD (1)  ·  Benjamin M Hibbert, MD, PhD (1)  ·  Caroline Vanpeteghem, MD (1)  ·  Dov Freimark, Prof. MD. (1)  ·  Erik Sloth, Professor (1)  ·  Jurgen Van Limmen, MD (1)  ·  Manuel B Schmid, Dr. med. (1)  ·  Rebecca Mathew, MD (1)  ·  Stefan W. Suttner, M.D. Ph.D. (1)  ·  Stephen R Watt-Smith, FDSRCS, MD (1)

Results publications

PMID 15519198, PMID 17331245, PMID 17377079, PMID 18279773, PMID 19114878, PMID 20156348, PMID 21546269, PMID 22429630, PMID 22929242, PMID 25032942, PMID 34347952, PMID 34376218, PMID 34713704, PMID 35261289

NIH funding

2008 (1)